The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications, accelerating early discovery innovation into the clinic.

Understand the very latest in construct design, immune cell biology, tumor associated activation, toxicity assessment, solid tumor targeting strategies, clinical insights and more.

Discover how to effectively scale complicated manufacturing of multi-specific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies.

With 22+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges.

To learn more about this event and to register online, visit https://ter.li/hkw9b8